Cancer Mortality Continuing to Decline
Mortality declined steadily from 2001 through 2022, including during the COVID-19 pandemic
Breast Cancer Outcomes Improved With History of Screening Mammography
Prior screening mammography linked to earlier stage at breast cancer diagnosis, lower breast cancer mortality
Supreme Court Case Targets Free Preventive Care Provided by the Affordable Care Act
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
PROSTOX predicts late genitourinary toxicity, yielding area under the curve of 0.76
Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer
Lower odds of receiving key components of quality care seen for those with high overall social vulnerability index
CT Exams in 2023 Projected to Result in 103,000 Future Cancers
Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers
Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma
ctDNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma
Breast, Colorectal Cancer Screening Higher Than Lung Cancer Screening
Among individuals eligible for lung cancer screening, use of BCS and CCS is much higher than use of LCS
C-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell Disease
CRP levels significantly higher during follicular versus luteal phase, which may contribute to pattern of painful vaso-occlusive events
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib
